The development and use of an intravenous preparation of allopurinol.
作者信息
Kann H E, Wells J H, Gallelli J F, Schein P S, Cooney D A, Smith E R, Seegmiller J E, Carbone P P
出版信息
Am J Med Sci. 1968 Jul;256(1):53-63. doi: 10.1097/00000441-196807000-00007.
Abstract
摘要
相似文献
1
The development and use of an intravenous preparation of allopurinol.别嘌醇静脉制剂的研发与应用。
Am J Med Sci. 1968 Jul;256(1):53-63. doi: 10.1097/00000441-196807000-00007.
2
Clinical efficacy and lack of toxicity of allopurinol (NSC-1390) given intravenously.静脉注射别嘌醇（NSC - 1390）的临床疗效及无毒性
Cancer Chemother Rep. 1970 Apr;54(2):125-9.
3
Management of acute renal failure due to marked hyperuricemia.因显著高尿酸血症所致急性肾衰竭的处理
Can Med Assoc J. 1972 Feb 19;106(4):352-4.
4
Evaluation of intravenous allopurinol (NSC-1390) in pediatric neoplasia.静脉注射别嘌醇（NSC-1390）在儿童肿瘤中的评估。
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):737-9.
5
[Renal electrolyte changes by allopurinol. A contribution in the prophylaxis of oxalic acid stones (author's transl)].别嘌醇引起的肾脏电解质变化。对草酸钙结石预防的一项贡献（作者译）
Urologe A. 1974 Jul;13(4 Pt A):166-7.
6
[Serum and urine uric acid content in hemoblastoses and gout as well as its modification by allopurinol].
Z Gesamte Inn Med. 1971 Apr 1;26(7):233-7.
7
Intravenous Allopurinol.静脉注射别嘌醇。
Clin J Oncol Nurs. 2002 Mar-Apr;6(2):110. doi: 10.1188/02.CJON.109-110.
8
[Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase].[信件：血液病理学中的高尿酸血症。使用尿酸氧化酶的治疗与预防]
Nouv Presse Med. 1974 Sep 28;3(32):2026.
9
[Allopurinol and hyperuricemia caused by fructose].
Arch Maragliano Patol Clin. 1968 Jul-Aug;24(4):395-406.
10
Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia.
N Engl J Med. 1973 Dec 20;289(25):1335-40. doi: 10.1056/NEJM197312202892503.
引用本文的文献
1
Allopurinol modulation of fluorouracil toxicity.
Cancer Chemother Pharmacol. 1981;5(3):151-5. doi: 10.1007/BF00258472.
Zotero 插件